Description
The medical device tax that took effect Jan. 1, 2013 for all manufacturers of Class I, Class II and Class III devices in the United States may have had an impact on device company spending, according to this complimentary Public Policy Paper from Kalorama Information. While the tax was in effect in the 2012 year, the paper looks at budgeted R&D spending as companies anticipated new costs from the program.
The conclusions are the result of information from Kalorama Information’s report “The Global Market for Medical Devices, 4th Edition.”
